111 related articles for article (PubMed ID: 10642352)
1. Endothelin-A blockade attenuates systemic and renal hemodynamic effects of L-NAME in humans.
Montanari A; Biggi A; Carra N; Fasoli E; Calzolari M; Corsini F; Perinotto P; Novarini A
Hypertension; 2000 Jan; 35(1 Pt 2):518-23. PubMed ID: 10642352
[TBL] [Abstract][Full Text] [Related]
2. Dopamine-2 receptor blockade potentiates the renal effects of nitric oxide inhibition in humans.
Montanari A; Tateo E; Fasoli E; Donatini A; Cimolato B; Perinotto P; Dall'Aglio P
Hypertension; 1998 Jan; 31(1 Pt 2):277-82. PubMed ID: 9453316
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockade blunts the renal effects of acute nitric oxide synthase inhibition in healthy humans.
Montanari A; Lazzeroni D; Pelà G; Crocamo A; Lytvyn Y; Musiari L; Cabassi A; Cherney DZI
Am J Physiol Renal Physiol; 2017 May; 312(5):F870-F878. PubMed ID: 28179255
[TBL] [Abstract][Full Text] [Related]
4. Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats.
Thompson A; Valeri CR; Lieberthal W
Am J Physiol; 1995 Aug; 269(2 Pt 2):H743-8. PubMed ID: 7653640
[TBL] [Abstract][Full Text] [Related]
5. Interactive modulation of renal myogenic autoregulation by nitric oxide and endothelin acting through ET-B receptors.
Shi Y; Lau C; Cupples WA
Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R354-61. PubMed ID: 16990488
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II blockade does not prevent renal effects of L-NAME in sodium-repleted humans.
Montanari A; Tateo E; Fasoli E; Giberti D; Perinotto P; Novarini A; Dall'Aglio P
Hypertension; 1997 Sep; 30(3 Pt 2):557-62. PubMed ID: 9322981
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ
Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857
[TBL] [Abstract][Full Text] [Related]
8. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
[TBL] [Abstract][Full Text] [Related]
9. Involvement of tumor necrosis factor-alpha in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice.
Shahid M; Francis J; Matrougui K; Majid DS
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F217-24. PubMed ID: 20410217
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II and prostaglandin interactions on systemic and renal effects of L-NAME in humans.
Perinotto P; Biggi A; Carra N; Orrico A; Valmadre G; Dall'aglio P; Novarini A; Montanari A
J Am Soc Nephrol; 2001 Aug; 12(8):1706-1712. PubMed ID: 11461943
[TBL] [Abstract][Full Text] [Related]
11. Protection from renal ischemia reperfusion injury by an endothelin-A receptor antagonist BQ-123 in relation to nitric oxide production.
Erdogan H; Fadillioglu E; Emre MH
Toxicology; 2006 Dec; 228(2-3):219-28. PubMed ID: 17046139
[TBL] [Abstract][Full Text] [Related]
12. Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat.
Kramp R; Fourmanoir P; Caron N
Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1132-40. PubMed ID: 11704565
[TBL] [Abstract][Full Text] [Related]
13. Renal effects of endothelin in anesthetized rabbits.
Ono N; Matsui T; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
Eur J Pharmacol; 1998 Oct; 359(2-3):177-84. PubMed ID: 9832389
[TBL] [Abstract][Full Text] [Related]
14. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
Matsuura T; Miura K; Ebara T; Yukimura T; Yamanaka S; Kim S; Iwao H
Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531
[TBL] [Abstract][Full Text] [Related]
15. Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure.
Lahera V; Salom MG; Miranda-Guardiola F; Moncada S; Romero JC
Am J Physiol; 1991 Dec; 261(6 Pt 2):F1033-7. PubMed ID: 1750517
[TBL] [Abstract][Full Text] [Related]
16. ET(B) receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit.
Gratton JP; Cournoyer G; Löffler BM; Sirois P; D'Orléans-Juste P
Hypertension; 1997 Nov; 30(5):1204-9. PubMed ID: 9369277
[TBL] [Abstract][Full Text] [Related]
17. Endothelial modulation of neural sympathetic vascular tone in canine skeletal muscle.
King-VanVlack CE; Curtis SE; Mewburn JD; Cain SM; Chapler CK
J Appl Physiol (1985); 1998 Oct; 85(4):1362-7. PubMed ID: 9760329
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of L-NAME-induced systemic and renal vasoconstrictor responses by alpha1-adrenoceptor antagonism.
van der Linde NA; Boomsma F; van den Meiracker AH
J Hypertens; 2005 May; 23(5):1017-24. PubMed ID: 15834288
[TBL] [Abstract][Full Text] [Related]
19. Impaired response of the denervated kidney to endothelin receptor blockade in normotensive and spontaneously hypertensive rats.
Girchev R; Bäcker A; Markova P; Kramer HJ
Kidney Int; 2004 Mar; 65(3):982-9. PubMed ID: 14871418
[TBL] [Abstract][Full Text] [Related]
20. Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME.
Broere A; Van Den Meiracker AH; Boomsma F; Derkx FH; Veld AJ; Schalekamp MA
Am J Physiol; 1998 Dec; 275(6):F870-7. PubMed ID: 9843903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
